Dr. ​Ilenia Pellicciotta

I specialize in tumor immunology, focusing on cancer treatment models and chemotherapy with immunotherapy. Previously, I researched tumor-associated antigens, immune activation, and the interaction of chemotherapy/radiotherapy and immune cells in breast, ovarian, and lung cancers at New York University. Currently, as a senior scientist at Columbia University, I evaluate tumor microenvironment and immune response to develop combination treatments for pancreatic cancer patients.

Dr. Alex Raufi

I am a hematologist/oncologist at the Lifespan Cancer Institute at Rhode Island and The Miriam hospitals, specializing in gastrointestinal oncology. I completed my fellowship at Columbia University/New York-Presbyterian and researche novel immunotherapy combinations for gastrointestinal malignancies. I am a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Association for Cancer Research.

Dr. Shiny Titus

I am a reproductive biologist by training with expertise in single cell transcriptomics. My previous research at Yale School of Medicine and FEC was focused on understanding the underlying mechanism of the effect of aging and chemotherapy on germ cells, and the cause of embryo arrest. Currently, as a Research Scientist at Columbia University my research endeavors are directed towards understanding the tumor microenvironment using Patient Derived Tumor Organoids (PDTOs) to develop new and more targeted treatment options for patients with Pancreatic Cancer

Dr. Morteza Chalabi

I am an ARS under the mentorship of Dr. Izar and Dr. Manji at Herbert Irving Comprehensive Cancer Center. My current main focuses are on pancreatic cancer and Wilms tumor in children. I am trying to understand gene expression programs driving the heterogeneity in these tumors.

Dr. Brian Labadie

I am currently a Hematology/Oncology Fellow. My clinical and research interest is on testing novel drugs in GI malignancy, in particular pancreas cancer. My current project involves targeting the adenosine immunosuppressive pathway in combination with radiation therapy in patients with localized pancreatic cancer.

Dr. ​Michael May

I am a Hematology/Oncology Fellow at Columbia. I am interested in clinical and translational research in gastrointestinal malignancies.

Isabelle Ross

I am a clinical research coordinator in the GI oncology department at Columbia University Medical Center. I help facilitate the gastrointestinal intestinal clinical oncology trials. My current laboratory projects involve exploring the efficacies of some novel GI therapies. Before my employment at Columbia, I studied public health and was a pre-medical student at the University of Vermont. I plan to apply to medical school in 2023 to pursue my M.D.